Stockreport

UPDATE 2-US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10 Tue, May 7, 2024, 3:51 PM GMT+2 1 min read 0 In this article: Advertisement Up next 1 High-Growth Tech Stock Set to S...

UiPath, Inc. Class A  (PATH) 
PDF FDA advisers will discuss its experimental Alzheimer's disease drug, donanemab, on June 10. Donanemab has faced two separate regulatory delays in the United States, wh [Read more]